KSPM
Search
- Page Path
- HOME > Search
English Abstract
- Costs of Initial Cancer Care and its Affecting Factors.
- So Young Kim, Sung Gyeong Kim, Jong Hyock Park, Eun Cheol Park
- J Prev Med Public Health. 2009;42(4):243-250.
- DOI: https://doi.org/10.3961/jpmph.2009.42.4.243
- 5,859 View
- 100 Download
- 10 Crossref
-
Abstract
PDF - OBJECTIVES
The purposes of this study is to estimate the cost of cancer care after its diagnosis and to identify factors that can influence the cost of cancer care. METHODS: The study subjects were patients with an initial diagnosis one of four selected tumors and had their first two-years of cancer care at a national cancer center. The data were obtained from medical records and patient surveys. We classified cancer care costs into medical and nonmedical costs, and each cost was analyzed for burden type, medical service, and cancer stage according to cancer types. Factors affecting cancer care costs for the initial phase included demographic variables, socioeconomic status and clinical variables. RESULTS: Cancer care costs for the initial year following diagnosis were higher than the costs for the following successive year after diagnosis. Lung cancer (25,648,000 won) had higher costs than the other three cancer types. Of the total costs, patent burden was more than 50% and medical costs accounted for more than 60%. Inpatient costs accounted for more than 60% of the medical costs for stomach and liver cancer in the initial phase. Care for late-stage cancer was more expensive than care for early-stage cancer. Nonmedical costs were estimated to be between 4,500,000 to 6,000,000 won with expenses for the caregiver being the highest. The factors affecting cancer care costs were treatment type and cancer stage. CONCLUSIONS: The cancer care costs after diagnosis are substantial and vary by cancer site, cancer stage and treatment type. It is useful for policy makers and researchers to identify tumor-specific medical and nonmedical costs. The effort to reduce cancer costs and early detection for cancer can reduce the burden to society and improve quality of life for the cancer patients. -
Summary
Citations
Citations to this article as recorded by
- Projecting Lifetime Health Outcomes and Costs Associated with the Ambient Fine Particulate Matter Exposure among Adult Women in Korea
Gyeyoung Choi, Yujeong Kim, Gyeongseon Shin, SeungJin Bae
International Journal of Environmental Research and Public Health.2022; 19(5): 2494. CrossRef - Expenditure and Financial Burden for Stomach Cancer Diagnosis and Treatment in China: A Multicenter Study
Kai Zhang, Jian Yin, Huiyao Huang, Le Wang, Lanwei Guo, Jufang Shi, Min Dai
Frontiers in Public Health.2020;[Epub] CrossRef - Early Detection is Important to Reduce the Economic Burden of Gastric Cancer
Jie-Hyun Kim, Sung Soo Kim, Jeong Hoon Lee, Da Hyun Jung, Dae Young Cheung, Woo-Chul Chung, Soo-Heon Park
Journal of Gastric Cancer.2018; 18(1): 82. CrossRef - Supporting Low-income Cancer Patients: Recommendations for the Public Financial Aid Program in the Republic of Korea
Hye Sook Min, Hyung Kook Yang, Keeho Park
Cancer Research and Treatment.2018; 50(4): 1074. CrossRef - Modeling lifetime costs and health outcomes attributable to secondhand smoke exposure at home among Korean adult women
Jiyae Lee, Ah Ram Han, Dalwoong Choi, Kyung-Min Lim, SeungJin Bae
BMJ Open.2017; 7(5): e013292. CrossRef - The Relief Effect of Copayment Decreasing Policy on Unmet Needs in Targeted Diseases
Jae-Woo Choi, Jae-Hyun Kim, Eun-Cheol Park
Health Policy and Management.2014; 24(1): 24. CrossRef - Changes in Economic Status of Households Associated with Catastrophic Health Expenditures for Cancer in South Korea
Jae-Woo Choi, Kyoung-Hee Cho, Young Choi, Kyu-Tae Han, Jeoung-A Kwon, Eun-Cheol Park
Asian Pacific Journal of Cancer Prevention.2014; 15(6): 2713. CrossRef - Medicaid inpatient costs and nested structural analysis using a hierarchical linear modeling (HLM) approach
Keon-Hyung Lee, Sang-Chul Park, Jungwon Park, Seunghoo Lim
Health Services and Outcomes Research Methodology.2013; 13(2-4): 157. CrossRef - Costs During the First Five Years Following Cancer Diagnosis in Korea
Ji-Yeon Shin, So Young Kim, Kun-Sei Lee, Sang-Il Lee, Young Ko, Young-Soon Choi, Hong Gwan Seo, Joo-Hyuk Lee, Jong-Hyock Park
Asian Pacific Journal of Cancer Prevention.2012; 13(8): 3767. CrossRef - Cost‐effectiveness of bevacizumab‐based therapy versus cisplatin plus pemetrexed for the first‐line treatment of advanced non‐squamous NSCLC in Korea and Taiwan
Myung‐Ju AHN, Chun‐Ming TSAI, Te‐Chun HSIA, Elaine WRIGHT, John Wen‐Cheng CHANG, Heung Tae KIM, Joo‐Hang KIM, Jin Hyoung KANG, Sang‐We KIM, Eun‐Jin BAE, Mijeong KANG, Johanna LISTER, Stefan WALZER
Asia-Pacific Journal of Clinical Oncology.2011; 7(s2): 22. CrossRef
Original ArticleTOP- A Study on the Association between Healthcare Utilization and the Burden of Families Caring for the Elderly in the Last 6 Months of Life.
- Jee Jeon Yi, Hee Na Lee, Heechoul Ohrr, Hye Young Jung, Sang Wook Yi
- Korean J Prev Med. 2003;36(4):332-338.
- 2,274 View
- 22 Download
-
Abstract
PDF
- OBJECTIVE
To investigate the relationship between medical expenses and the burden of families caring for the elderly in the last 6 months of life, and to evaluate the factors relating to the burden of family caregivers. METHODS: The families of 301 persons older than 65 years, who died between 1 July and 31 December 2001, and were registered in Resident-based- Health Insurance Programs in Seoul, were interviewed. The medical expenses and length of stay among the elderly were collected from Korean Health Insurance Corporations. RESULTS: 31 percents of the elderly had no medical expenses in the last 6 months of life. On average, the objective burden (4.92) was higher than the subjective burden (3.35). Families caring for male elderly had a higher burden. With increasing age at death, the objective burden was significantly increased. The burden on a family seemed to be influenced more by the family income than the property of the elderly. With increasing total health care costs, the objective burden on the family caregivers was significantly increased, but with increasing medical expenses, the subjective burden was significantly decreased. CONCLUSION: An association between healthcare utilization and burden on families was observed. The reason for the decreasing subjective burden when medical expenses were decreased was unclear. Further research will be needed. -
SummaryEnglish Abstract
- Medical Expenses by Site of Cancer and Survival Time among Cancer Patients in the Last One Year of Life.
- Jee Jeon Yi, Won Kon Yoo, So Yoon Kim, Kwang Ki Kim, Sang Wook Yi
- J Prev Med Public Health. 2005;38(1):9-15.
- 2,270 View
- 67 Download
-
Abstract
PDF
- OBJECTIVES
To analyze medical expenses by cancer site and survival time among cancer patients in their last year of life. METHOD: The study subjects were 45, 394 people that had died of cancers in 2002, were registered by the Korea Central Cancer Registry and received National Health Insurance benefit in the last year (360 days) of life. Personal identification data, general characteristics, dates of death and cancer incidence, and site of cancer were collected from the National Statistical Office and the Korea Central Cancer Registry, and merged with the data of the individual medical expenses of the Health Insurance Review Agency. RESULTS: Average monthly cost curves were U-shaped with high costs near the time of diagnosis and death, and lower costs in between. Medical expenses in the last year of life were around 30.3, 16.7, 13.0, and 12.1 million won among leukemia, lymphoma, ovarian cancer, and breast cancer patients, respectively. Digestive organ cancers including stomach, esophagus, liver, pancreas, and colorectal cancers had relatively low medical expenses. Medical expenses in the last year of life were inverse U-shaped with high expenses near one year of survival. Average monthly cost in the 12 months before death among the patients who had survived 10~15 years were more than two-fold greater than the cost before diagnosis among those who had survived for less than one year. CONCLUSIONS: Leukemia was the most expensive cancer. It is possible that once diagnosed as cancer, medical expenses do not return to the level before diagnosis. Further research will be needed to understand the magnitude and change of the medical expenses among cancer patients with long term follow up data. -
SummaryOriginal Article
- A Study on the Cost and Proportion of Complementary and Alternative Medicine in Total Healthcare Cost among Elderly in the Last 6 Months of Life.
- Jee Jeon Yi, Heechoul Ohrr, Sang Wook Yi
- J Prev Med Public Health. 2004;37(2):141-149.
- 2,142 View
- 41 Download
-
Abstract
PDF
- OBJECTIONS: To evaluate the cost and proportion of complementary and alternative medicines (CAM) in the total healthcare costs among the elderly in the last 6 months of life. METHODS: The care-giving families of 301 persons older than 65 years, who died between July 1st and December 31st of 2001, and were also registered in Self-Employed Health Insurance Programs in Seoul, were interviewed. RESULTS: The cost of CAM was 1.09 million Won, which as a proportion of the total healthcare cost was 38.1%. The elderly aged between 65 and 69 year-old, male, living with their spouse, Buddhist and having cancers had higher CAM costs in an ANOVA and simple regression analysis. After controlling of various factors, age was the only significant factor associated with the cost of CAM. The elderly above 80 years old, female, bereaved and Buddhist had higher proportional CAM costs, and the elderly having cancers or cardiovascular diseases had lower proportional CAM costs in an ANOVA and simple regression analysis. After adjusting for various factors, the elderly above 85 years old, female and Buddhist had higher proportional CAM costs, and the elderly having cancers had lower proportional CAM costs. CONCLUSION: The very old and Buddhist, and/or the ill with no clear diagnosis, may depend more on CAM. Further research will be needed on the meaning and impact of CAM and their costs to public health and the total healthcare system.
-
Summary
First
Prev
